The outcomes of most of the presented experiments support our conclusion that oral ingestion of PS48 reached its molecular target, the PI3K-PDK-1/Akt-1 activation axis, in the APPswe/PS1E9 AD transgenic mouse brain on either diet regimen. This evidence concerns the gene PDK1 and Alzheimer disease.